Drug intelligence / Profile preview

Neuragen

Development stage
Unknown
Lead developer
Knight Therapeutics
Modality
Small Molecules
Administration
Topical
01

Overview

Neuragen is a topical natural health product (NHP) formulated as an oil for the treatment of peripheral neuropathic pain. It contains a proprietary blend of plant-derived lipophilic molecules that rapidly penetrate the skin to reach affected peripheral nerves. The primary mechanism of action involves reducing the spontaneous firing (ectopic discharge) of damaged nerves, which provides rapid relief from pain associated with conditions such as diabetic neuropathy, post-herpetic neuralgia, and fibromyalgia. Originally developed by Origin BioMed, the worldwide rights were acquired by Knight Therapeutics in 2015, though the U.S. commercial rights were subsequently divested to Synergy Strips Corp. The product is available over-the-counter (OTC) and has been evaluated in randomized, double-blind, placebo-controlled clinical studies.

Brand names
NeuragenNeuragen PN
Other names
Neuragen PN

Beyond the preview

Go deeper on Neuragen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuragen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call